Base to Base biotech podcast 41: Eyes, mitochondria and a growing hub
LoQus23 Therapeutics nominates first-in-class oral drug candidate for Huntington’s disease
Earendil Labs to collaborate with Sanofi on bispecific antibodies for autoimmune diseases
Insilico Medicine announces $888m collaboration with Servier
Study identifies which patients benefit most from new schizophrenia drug
Mechanism behind overactive immune cells revealed
Investigational treatment of autosomal dominant polycystic kidney disease receives orphan drug designation
World’s first gene-editing therapy for hyperlipidemia
Positive results for Lilly obesity drug
“Foundational moment for in vivo cell therapy”
Cooperative motor proteins kill cancer cells when dual-inhibited
SanegeneBio announces collaboration with Lilly